GNUV201 has an anti-cancer effect equivalent to Keytruda® and Opdivo® in MC38/hPD-1 KI mice and shows a strong tumor regression effect in B16F10 and Pan02 (Fig. 5). The gene discussed is PDCD1; the disease is neoplasm.